determining optimal working concentration by titration.
References
1. Yang, A., et al., Mol. Cell, 2, 305-316 (1998).
2. Chen, X., Mol. Med. Today, 5, 387-392 (1999).
3. Levrero, M., et al., Cell Death Differ
determining optimal working concentration by titration.
References
1. Yang, A., et al., Mol. Cell, 2, 305-316 (1998).
2. Yang, A., et al., Nature, 398, 714-718 (1999).
3. Signoretti, S., et al., Am. J. Pathol
Danieli, et al., Helv. Chim. Acta, 1997, 80, 1153.
65 S. Riva, et al., Carbohydrate Research,1998, 305, 525.
66 B. Danieli, et al., J. Org. Chem., 2001, 66, 262.
67 S. Gebhard, et al.
Biomaterials 26, 971–977.
37. Lian, J. B. & Stein, G. S. (1992) Crit. Rev. Oral Biol. Med. 3, 269–305.
38. Holtorf, H. L., Datta, N., Jansen, J. A. & Mikos, A. G. (2005) J. Biomed. Mater.
Res. A 74
monocyte chemoattractant protein-1 in healthy and critically ill
dogs. Vet Clin Pathol 2010; 39: 302–305.
30. Olsson M, Frankowiack M, Tengvall K et al. The dog as a genetic
model for immunoglobulin A
M NP_005304.3 y y n/d
306 Glycogen Synthase Kinase-3 (GSK-3) G4414 2931 GSK3A M NP_063937.2 y y y
305 Glycogen Synthase Kinase-3? (GSK-3?) G7914 2932 GSK3B P NP_001139628.1,NP_002084.2 y n/d y
307 Glycogen
M NP_005304.3 y y n/d
306 Glycogen Synthase Kinase-3 (GSK-3) G4414 2931 GSK3A M NP_063937.2 y y y
305 Glycogen Synthase Kinase-3? (GSK-3?) G7914 2932 GSK3B P NP_001139628.1,NP_002084.2 y n/d y
307 Glycogen
M NP_005304.3 y y n/d
306 Glycogen Synthase Kinase-3 (GSK-3) G4414 2931 GSK3A M NP_063937.2 y y y
305 Glycogen Synthase Kinase-3? (GSK-3?) G7914 2932 GSK3B P NP_001139628.1,NP_002084.2 y n/d y
307 Glycogen
G6670 M y y y
303 Glutamate receptor NMDAR 2a G9038 P y y y
304 Glutamine Syntethase G2781 P n/d n/d y
305 Glycogen Synthase Kinase-3β (GSK-3β) G7914 P y n/d y
306 Glycogen Synthase Kinase-3 (GSK-3) G4414 M
Gaestel, M. and Shi, Y. 2002. Biol. Chem., Vol. 383:
1519-1536.
Kolch, W. 2000. Biochem. J. 351:289-305.
Pomerance, M. et al. 2000. J. Biol. Chem. 275(51):
40539-40546.
Ishitani, T. et al. 1999. Nature